You are here: Industry Insights > SARS-CoV-2

News List

Genalyte Obtains EUA for Rapid COVID-19 Antibody Test americanpharmaceuticalreview
October 22, 2020
Genalyte announced its SARS-CoV-2 Multi-Antigen Serology Panel has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
SARS-CoV-2 vaccine safely induces an immune response in healthy volunteers europeanpharmaceuticalreview
October 22, 2020
The Chinese COVID-19 vaccine candidate BBIBP-CorV elicited an antibody response in all recipients, according to preliminary Phase I/II trial data.
ImmunityBio, NantKwest begin patient dosing in Phase 1 clinical trial of COVID-19 vaccine candidate expresspharma
October 22, 2020
The Phase 1 trial, being conducted at the Hoag Hospital in Newport Beach, California, is enrolling healthy adult subjects up to age 55 to examine the safety and reactogenicity of two doses of the vaccine candidate.
Inhaled antibody treatment for COVID-19 shows success in pre-clinical trials europeanpharmaceuticalreview
October 22, 2020
Researchers have developed a monoclonal antibody called AR-711 that is highly neutralising against COVID-19 in an inhaled formulation.
The Doc Announces New Rapid Detection SARS-CoV-2 Antibody Test Kit, Plans to Alleviate COVID-19 Testing Delays prnewswire
October 22, 2020
The Doc, LLC. announced the development of a new rapid detection serological antibody test kit for SARS-CoV-2, the virus that causes COVID-19. With results in minutes using only a drop of blood, the Company's IgM/IgG antibody test has been submitted for..
Scientists identify common vulnerabilities across SARS-CoV-2, SARS-CoV-1 and MERS coronaviruses worldpharmanews
October 21, 2020
In a study published online in Science, an international team of almost 200 researchers from 14 leading institutions in six countries, including France with the Institut Pasteur and CNRS, studied the three lethal coronaviruses SARS-CoV-2, SARS-CoV-1 ...
BioGX Announces EUA for Extraction-Free Direct RT-PCR Test for COVID-19 americanpharmaceuticalreview
October 16, 2020
BioGX announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.
US FDA authorises phase 1 trial of ImmunityBio’s COVID-19 vaccine candidate hAd5 expresspharma
October 16, 2020
Ongoing development proceeding for oral, inhalational and intranasal administration of hAd5.
Remdesivir alone or in combination with other drugs considered most promising drug for COVID-19: Poll pharmaceutical-technology
October 16, 2020
The COVID-19 infection caused by the SARS-CoV-2 currently does not have any treatment although several existing approved drugs are being used to treat the disease symptoms.
Beckman Coulter SARS-CoV-2 IgM Antibody Test Receives Emergency Use Authorization americanpharmaceuticalreview
October 16, 2020
Beckman Coulter announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page